BR0210410A - Processo para produção do derivado de piperidina, fexofenadina - Google Patents

Processo para produção do derivado de piperidina, fexofenadina

Info

Publication number
BR0210410A
BR0210410A BR0210410-5A BR0210410A BR0210410A BR 0210410 A BR0210410 A BR 0210410A BR 0210410 A BR0210410 A BR 0210410A BR 0210410 A BR0210410 A BR 0210410A
Authority
BR
Brazil
Prior art keywords
production
fexofenadine
piperidine derivative
processes
relates
Prior art date
Application number
BR0210410-5A
Other languages
English (en)
Inventor
Collin Schroeder
Ryan Huddleston
Richard Charles
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of BR0210410A publication Critical patent/BR0210410A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"PROCESSO PARA PRODUçãO DO DERIVADO DE PIPERIDINA, FEXOFENADINA". A presente invenção refere-se a processos para preparação de certos derivados de piperidina, incluindo fexofenadina (F) (ver Esquema), o ingrediente ativo da anti-histamina não-sedativa vendida nos Estados Unidos com a designação de "Allegra<32>". Esta invenção também refere-se a novos intermediários sintéticos úteis nos processos da presente invenção.
BR0210410-5A 2001-06-15 2002-06-12 Processo para produção do derivado de piperidina, fexofenadina BR0210410A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29839701P 2001-06-15 2001-06-15
PCT/EP2002/006424 WO2002102776A1 (en) 2001-06-15 2002-06-12 Process for the production of the piperidine derivative fexofenadine

Publications (1)

Publication Number Publication Date
BR0210410A true BR0210410A (pt) 2004-08-17

Family

ID=23150325

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0210410-5A BR0210410A (pt) 2001-06-15 2002-06-12 Processo para produção do derivado de piperidina, fexofenadina

Country Status (23)

Country Link
US (2) US6743941B2 (pt)
EP (1) EP1401816B1 (pt)
JP (1) JP4344230B2 (pt)
KR (1) KR100903285B1 (pt)
CN (1) CN1229347C (pt)
AR (1) AR037005A1 (pt)
AT (1) ATE386021T1 (pt)
AU (1) AU2002320847B2 (pt)
BR (1) BR0210410A (pt)
CA (1) CA2450313C (pt)
DE (1) DE60225008T2 (pt)
DK (1) DK1401816T3 (pt)
ES (1) ES2298384T3 (pt)
HK (1) HK1063795A1 (pt)
HU (1) HUP0401125A2 (pt)
IL (2) IL159304A0 (pt)
MX (1) MXPA03010960A (pt)
NO (1) NO20035572L (pt)
NZ (1) NZ530153A (pt)
PL (1) PL364369A1 (pt)
PT (1) PT1401816E (pt)
WO (1) WO2002102776A1 (pt)
ZA (1) ZA200308697B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7498443B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of carebastine
US7498345B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
CN100453522C (zh) * 2005-01-26 2009-01-21 中国科学技术大学 4-[4-(1-乙氧基酰基-1-甲基乙基苯)]-4-氧代丁酸的制备方法
WO2007135693A2 (en) * 2006-05-18 2007-11-29 Ind-Swift Laboratories Limited Intermediates useful for the preparation of antihistaminic piperidine derivative
ITMI20061492A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
ITMI20061491A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
CN102070490B (zh) * 2009-11-21 2014-07-30 浙江华海药业股份有限公司 一种非索非那定中间体2-(4-(4-羟基丁酰基)苯基)-2-甲基丙氰的制备方法
CN102070570A (zh) * 2009-11-21 2011-05-25 浙江华海药业股份有限公司 一种非索非那定中间体2-甲基-2(4-(2-氧代四氢呋喃-3-羰基)苯基)丙氰及其盐的制备方法
DK3842429T3 (da) 2015-06-15 2022-11-07 Asana Biosciences Llc Heterocykliske inhibitorer af ERK1 og ERK2 og anvendelse deraf i behandling af cancer
CN104876853B (zh) * 2015-06-17 2017-06-16 苏州卫生职业技术学院 盐酸非索非那定的合成方法
HUE047669T2 (hu) 2015-10-22 2020-05-28 Sanofi Aventis Deutschland Eljárás fexofenadin és az eljárásban használt köztitermékek elõállítására
CA3158910A1 (en) 2019-10-28 2021-05-06 Asana Biosciences, Llc Improved methods, kits, compositions and dosing regimens for the use of heterocyclic inhibitors of erk1 and erk2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2946809A1 (de) * 1979-11-20 1981-06-11 A. Nattermann & Cie GmbH, 5000 Köln 4-phenyl-4-oxo-buttersaeuren, deren salze und ester, verfahren zu deren herstellung und diese enthaltende arzneimittel
IT1200123B (it) 1985-09-27 1989-01-05 Ind Chimica Srl Procedimento per la preparazione di alfa-(p-terbutilfenil)-4-(idrossidifenilmetil)-1-piperidinobutanolo
EP0347123A3 (en) 1988-06-17 1991-07-03 Fisons Corporation Dibenzo-cycloheptenyl, -cycloheptyl and -oxepinyl amines having antihistaminic properties
IT1249684B (it) 1991-07-19 1995-03-09 Sorin Biomedica Spa Epitopi della proteina env del virus dell'epatite c.
AU671822B2 (en) * 1992-04-10 1996-09-12 Aventisub Ii Inc. 4-diphenylmethyl piperidine derivatives and process for their preparation
EP0703902B1 (en) 1993-06-24 1998-12-16 Albany Molecular Research, Inc. Process for the production of piperidine derivatives

Also Published As

Publication number Publication date
KR20040010720A (ko) 2004-01-31
US6743941B2 (en) 2004-06-01
HK1063795A1 (en) 2005-01-14
DE60225008D1 (de) 2008-03-27
WO2002102776A1 (en) 2002-12-27
AU2002320847B2 (en) 2007-09-20
EP1401816A1 (en) 2004-03-31
JP2005502603A (ja) 2005-01-27
NZ530153A (en) 2005-07-29
CN1516689A (zh) 2004-07-28
NO20035572D0 (no) 2003-12-12
MXPA03010960A (es) 2004-02-27
CA2450313C (en) 2010-08-10
US7235665B2 (en) 2007-06-26
US20030105329A1 (en) 2003-06-05
CN1229347C (zh) 2005-11-30
ES2298384T3 (es) 2008-05-16
HUP0401125A2 (hu) 2004-09-28
DK1401816T3 (da) 2008-06-09
AR037005A1 (es) 2004-10-20
ATE386021T1 (de) 2008-03-15
US20040198983A1 (en) 2004-10-07
ZA200308697B (en) 2004-09-03
EP1401816B1 (en) 2008-02-13
IL159304A0 (en) 2004-06-01
KR100903285B1 (ko) 2009-06-17
PL364369A1 (en) 2004-12-13
NO20035572L (no) 2004-02-16
DE60225008T2 (de) 2009-01-29
CA2450313A1 (en) 2002-12-27
JP4344230B2 (ja) 2009-10-14
PT1401816E (pt) 2008-04-08
IL159304A (en) 2010-02-17

Similar Documents

Publication Publication Date Title
HK1089444A1 (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
NO20040680D0 (no) Nye dihydropterinonerfremgangsmate for fremstilling derav og deres anvendelse som legemiddel
BR0210410A (pt) Processo para produção do derivado de piperidina, fexofenadina
BR0316375A (pt) Diazinopirimidinas
NO20062644L (no) DPP-IV inhibitorer
DOP2002000512A (es) Sales de acido succinato de 5,7,14-triazatetraciclo [10.3.1.0² ¹¹.04,9] hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas
BR0209580A (pt) Derivados de ciclohexan-1, 4 diamina substituìdos
BR0017030A (pt) Derivados de tiazolilamida
BR0017043A (pt) Imidazo[1,3,5]triazinonas e sua aplicação
BR0208741A (pt) Derivados de piperidina
PT1259498E (pt) Derivados do 8,8a-di-hidroindeno[1,2-d]tiazole substituidos na posicao 8a, processo para a sua preparacao e sua utilizacao como medicamentos, p. ex. como anorecticos
BR0007643A (pt) Processo para obter ésteres de (nitroximetil) fenila de derivados de aspirina, e, (hidroximetil) feniléter de derivados de aspirina
BR9808770A (pt) Conjugado medicamentoso, método para suaprodução e seu uso
PT1265888E (pt) Processo para producao de derivados de (s)-nicotina 6-substituida e compost0s intermediarios
BR0110357A (pt) Sais bicìclicos e n-aciclados de aminas imidazo - 3 e imidazo -5
BR0108990A (pt) Processo para preparação de derivados de pirimidona com atividade antifungos
BR0011996A (pt) Preparação de piperidin-4-onas substituìdas
ATE389405T1 (de) Fexofenadine hydrochlorid polymorph
BR0013313A (pt) Derivados substituìdos de pirrolidino-2,3,4- triona-3-oxina eficazes como antagonistas de receptores de nmda
BRPI0411652A (pt) processo para a preparação de derivados de espirobenzoazepina substituìdos não-peptìdicos
UY27001A1 (es) Derivados de la indolilpiperidina como agentes antihistamínicos y antialérgicos
PT1246790E (pt) Bases de mannich de 1- e 2-naftol substituido
PT1347960E (pt) Processo para a preparacao de (+)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperidina
PT703232E (pt) Derivados do 2,3-di-hidro-1h-isoindole processo para a sua preparacao e o seu uso como inibidores da reassimilacao da serotonina
EA200300771A1 (ru) Новая соль бензоилгуанидина

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE)

Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INTE.CL: C07D 211/22, C07C 69/730

Ipc: C07D 211/22 (2011.01), C07C 69/738 (2011.01), A61P

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 8A E 9A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011.